In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Transcript of the Earning Conference Call scheduled on Friday, May 15, 2026, on the financial performance of the Company for the Fourth Quarter and Financial Year ended on March 31, 2026, is enclosed herewith.
AETHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aether Industries reported FY26 revenue of INR11,601 million (up 38% YoY) with EBITDA of INR3,547 million (margin 31%) and PAT of INR2,195 million (margin 19%). Q4 saw sequential decline due to one-off items including INR70 million fire inventory provision and absence of INR200 million FLOP claim income from Q3. LSM segment pricing increased over 20% YoY due to global supply disruptions, and management expects elevated prices to sustain for 2-3 quarters. Three new products from Site 5 (2 pharma, 1 agro) will commission by May-June with orders already in hand. Management targets 70% revenue from CRAMS/CEM by FY30 versus current 55%. Working capital improved to 179 days from 194 days, with target of 150-160 days by FY27. FY27 capex guidance is INR3,000-3,500 million.
Strong full-year growth driven by pricing power and new product ramp-up. Q4 one-off items created a temporary margin dip, but management guided stable EBITDA margins of 29-30% and PAT of 19-20% for FY27, with Site 5 commercialization and semiconductor materials opportunity expected to drive medium-term growth.